Cargando…

Proton-Pump Inhibitors Suppress T Cell Response by Shifting Intracellular Zinc Distribution

Proton-pump inhibitors (PPI), e.g., omeprazole or pantoprazole, are the most widely used drugs for various gastrointestinal diseases. However, more and more side effects, especially an increased risk of infections, have been reported in recent years. The underlying mechanism has still not yet been f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wenlei, Jakobs, Jana, Rink, Lothar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867219/ https://www.ncbi.nlm.nih.gov/pubmed/36674704 http://dx.doi.org/10.3390/ijms24021191

Ejemplares similares

B cell activation and proliferation increase intracellular zinc levels()
por: Ollig, Johanna, et al.
Publicado: (2019)

Proton Pump Inhibitors Interfere With Zinc Absorption and Zinc Body Stores
por: Farrell, Christopher P., et al.
Publicado: (2011)

Short-term zinc supplementation of zinc-deficient seniors counteracts CREMα - mediated IL-2 suppression
por: Baarz, Bastian Robinson, et al.
Publicado: (2022)

Increase of the Intracellular Zinc Concentration Leads to an Activation and Internalisation of the Epidermal Growth Factor Receptor in A549 Cells
por: Barth, Lisa-Marie, et al.
Publicado: (2020)

The Intracellular Free Zinc Level Is Vital for Treg Function and a Feasible Tool to Discriminate between Treg and Activated Th Cells
por: Maywald, Martina, et al.
Publicado: (2018)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Zinc in Infection and Inflammation
por: Gammoh, Nour Zahi, et al.
Publicado: (2017)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Zinc in Human Health and Infectious Diseases
por: Maywald, Martina, et al.
Publicado: (2022)

Zinc Signals and Immunity
por: Maywald, Martina, et al.
Publicado: (2017)

Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases
por: Overbeck, Silke, et al.
Publicado: (2008)

The immune system and the impact of zinc during aging
por: Haase, Hajo, et al.
Publicado: (2009)

Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors
por: Yu, Man, et al.
Publicado: (2015)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Zinc as a Gatekeeper of Immune Function
por: Wessels, Inga, et al.
Publicado: (2017)

Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness
por: Brett, Stephen
Publicado: (2005)

Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis
por: Ghebremariam, Yohannes T, et al.
Publicado: (2015)

Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase
por: Zheng, Mengzhu, et al.
Publicado: (2017)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis
por: Wessels, Inga, et al.
Publicado: (2020)

Clinical Predictors for Response to Proton Pump Inhibitor Treatment in Patients With Globus
por: Jeon, Hye Kyung, et al.
Publicado: (2013)

The Essential Toxin: Impact of Zinc on Human Health
por: Plum, Laura M., et al.
Publicado: (2010)

Gastric Epithelial Cell Modality and Proton Pump Inhibitor
por: Masaoka, Tatsuhiro, et al.
Publicado: (2008)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011)

Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
por: Swaminathan, Krishnan
Publicado: (2015)

Proton pump inhibitors: A balanced view
por: Ramakrishna, B.S.
Publicado: (2015)

Proton Pump Inhibitors: The Culprit for Barrett’s Esophagus?
por: Alsalahi, Omran, et al.
Publicado: (2015)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Proton Pump Inhibitor-associated Mucosal Change
por: Kato, Mototsugu, et al.
Publicado: (2017)

Proton pump inhibitors induce hemolytic anemia
por: Al-Nasser, Asayil Nasser, et al.
Publicado: (2019)

When is proton pump inhibitor use appropriate?
por: Yadlapati, Rena, et al.
Publicado: (2017)

Use of proton pump inhibitors in general practice
por: Tosetti, Cesare, et al.
Publicado: (2017)

Effect of Proton Pump Inhibitors on Colorectal Cancer
por: Sasaki, Takamitsu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_98m5o0vpinpi72ed8nf8paco4r